NCT04740580View on ClinicalTrials.gov

Glutathione, Brain Metabolism and Inflammation in Alzheimer's Disease

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

December 31, 2026

Conditions
Alzheimer Disease
Interventions
DIETARY_SUPPLEMENT

Glycine

The active arm will supplement a combination of glycine and N-acetylcysteine (GlyNAC)

DIETARY_SUPPLEMENT

N-acetylcysteine

The active arm will supplement a combination of glycine and N-acetylcysteine (GlyNAC)

DIETARY_SUPPLEMENT

Alanine

The placebo arm will supplement Alanine

Trial Locations (1)

77030

RECRUITING

Baylor College of Medicine, Houston

All Listed Sponsors
collaborator

The Methodist Hospital Research Institute

OTHER

lead

Baylor College of Medicine

OTHER